Mesa Laboratories (MLAB)

• Market cap: $385M
• 1 day: -2.82%
• 5 days: 0.44%
• 1 month: -9.36%
• 3 months: -38.14%
• 6 months: -51.54%
• Year to date: -46.93%
• 1 year: -49.16%
• 5 years: -70.82%
• 10 years: -35.75%
• Sector: Technology
• Industry: Scientific & Technical Instruments

About: Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.

Employees: 730

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

26% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 19

0% more funds holding

Funds holding: 152 [Q1] → 152 (+0) [Q2]

0.29% less ownership

Funds ownership: 95.24% [Q1] → 94.95% (-0.29%) [Q2]

11% less repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 53

20% less capital invested

Capital invested by funds: $614M [Q1] → $488M (-$126M) [Q2]

Research analyst outlook

1 Wall Street Analyst provided 1 year price targets over the past 3 months

• Low target: $67 4% downside
• Avg. target: $67 4% downside
• High target: $67 4% downside

1 analyst rating

• positive: 0 0%
• neutral: 1 100%
• negative: 0 0%

Wells Fargo Brandon Couillard

4% downside $67

Equal-Weight Upgraded

8 Aug 2025